Neurogenetics Publications
NYU Langone’s Division of Neurogenetics faculty publish frequently in prestigious, peer-reviewed journals. Here is a selection of their recent publications.
Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy
Current oncology reports. 2026 Aug 21; 28:
Long-term real-world safety and effectiveness of arimoclomol in individuals with NPC: Outcomes from the US early access program over a 4-year period
Molecular genetics & metabolism. 2026 Jul 28; 149:110223
Neurofilament light chain (NfL) as a surrogate outcome measure for GM2 gangliosidoses
Journal of neurology. 2026 Jul 17; 273:
Incidence and predictors of hemorrhage in pediatric low-grade glioma
Journal of neuro-oncology. 2026 Jul 07; 178:
Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET
Genetics in medicine. 2026 Jun 19; 102637
Eladocagene Exuparvovec for the Treatment of Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): An Economic Evaluation from a US Perspective
Pharmacoeconomics. 2026 Jan ; 44:25-41
The Association Between Age and Outcomes of Bevacizumab Treatment in NF2-Related Schwannomatosis
Otology & neurotology. 2026 Feb 01; 47:370-377
Causes of Diplopia, Strabismus Patterns, and Ocular Motor Features in Patients With Spinocerebellar Ataxia Type 27B
Journal of neuro-ophthalmology. 2026 Mar 01; 46:73-80